Skip to main content
. 2017 Jul 21;22(4):491–500. doi: 10.1007/s12603-017-0952-x

Table 4.

The incidence of new upper respiratory tract infection every four weeks after the start of intake of the trial supplement

graphic file with name 12603_2017_952_Fig5_HTML.jpg